Compare
DMRA · 1 ticker
Price
100 is the close on the leftSnapshot
best blue · worst red
DMRA
Damora Therapeutics Inc
22.05
-1.20 (-5.16%)
Valuation
| Index | RUT |
|---|---|
| Market Cap | $1.36B |
| Enterprise Value | 967.62M |
| Income | -291.68M |
| Sales | 0.00M |
| Book / share | 5.91 |
| Cash / share | 8.54 |
| Dividend Gr. 3/5Y | - - |
| Employees | 7 |
| IPO | Oct 29, 2020 |
Ratios
| Price / book | 3.73 |
|---|---|
| Price / cash | 2.58 |
| Quick Ratio | 14.76 |
| Current Ratio | 14.76 |
| Debt / equity | 0.00 |
| Long-term debt / equity | 0.00 |
| Options and short | No / Yes |
Earnings
| Earnings / share | -122.94 |
|---|---|
| Earnings next year | -2.15 |
| Earnings next quarter | -0.55 |
| Earnings this year | 49.75% |
| Earnings growth, 5 years | 13.44% |
| Past earnings growth | -36.14% -34.72% |
| Past sales growth | - - |
| Earnings vs last year | -916.03% |
| Earnings vs last quarter | 78.08% |
| Earnings | Nov 04 AMC · 9 days ago |
| Surprise | 17.10% - |
Ownership
| Insiders own | 22.08% |
|---|---|
| Insider trades | 0.09% |
| Institutions own | 89.39% |
| Institution trades | 12.10% |
| Return on assets | -107.36% |
| Return on equity | -116.11% |
| Return on capital | -58.72% |
| 20-day average | 0.98% |
| 50-day average | -1.21% |
| 200-day average | -13.55% |
Technical
| Shares out | 61.90M |
|---|---|
| Shares floating | 48.25M |
| Short / float | 9.72% |
| Short ratio | 8.53 |
| Short interest | 4.69M |
| 52-week high | 38.33 -42.5% |
| 52-week low | 15.76 +39.9% |
| Volatility | 8.18% 8.09% |
| Average range | 1.76 |
| Strength index | 49.16 |
| Market sensitivity | 1.51 |
| Relative volume | 0.00 |
| Avg Volume | 549.48K |
| Volume | 0 |
Performance
| Perf Week | 0.87% |
|---|---|
| Perf Month | 19.64% |
| Perf Quarter | -28.96% |
| Perf Half Y | -7.66% |
| Perf YTD | -4.17% |
| Perf Year | -6.57% |
| Perf 3Y | 52.07% |
| Perf 5Y | -75.15% |
| Recommendation | 1.00 |
| Target Price | 46.78 |
| Prev Close | 22.05 |
| Price | 22.05 |
| Change % | 0.00% |
Compare
| DMRA | |
|---|---|
| Price | 22.05 |
| Change | -1.20 (-5.16%) |
Compare · Valuation
| DMRA | |
|---|---|
| Index | RUT |
| Market Cap | $1.36B |
| Enterprise Value | 967.62M |
| Income | -291.68M |
| Sales | 0.00M |
| Book / share | 5.91 |
| Cash / share | 8.54 |
| Dividend Gr. 3/5Y | - - |
| Employees | 7 |
| IPO | Oct 29, 2020 |
Compare · Ratios
| DMRA | |
|---|---|
| Price / book | 3.73 |
| Price / cash | 2.58 |
| Quick Ratio | 14.76 |
| Current Ratio | 14.76 |
| Debt / equity | 0.00 |
| Long-term debt / equity | 0.00 |
| Options and short | No / Yes |
Compare · Earnings
| DMRA | |
|---|---|
| Earnings / share | -122.94 |
| Earnings next year | -2.15 |
| Earnings next quarter | -0.55 |
| Earnings this year | 49.75% |
| Earnings growth, 5 years | 13.44% |
| Past earnings growth | -36.14% -34.72% |
| Past sales growth | - - |
| Earnings vs last year | -916.03% |
| Earnings vs last quarter | 78.08% |
| Earnings | Nov 04 AMC · 9 days ago |
| Surprise | 17.10% - |
Compare · Ownership
| DMRA | |
|---|---|
| Insiders own | 22.08% |
| Insider trades | 0.09% |
| Institutions own | 89.39% |
| Institution trades | 12.10% |
| Return on assets | -107.36% |
| Return on equity | -116.11% |
| Return on capital | -58.72% |
| 20-day average | 0.98% |
| 50-day average | -1.21% |
| 200-day average | -13.55% |
Compare · Technical
| DMRA | |
|---|---|
| Shares out | 61.90M |
| Shares floating | 48.25M |
| Short / float | 9.72% |
| Short ratio | 8.53 |
| Short interest | 4.69M |
| 52-week high | 38.33 -42.5% |
| 52-week low | 15.76 +39.9% |
| Volatility | 8.18% 8.09% |
| Average range | 1.76 |
| Strength index | 49.16 |
| Market sensitivity | 1.51 |
| Relative volume | 0.00 |
| Avg Volume | 549.48K |
| Volume | 0 |
Compare · Performance
| DMRA | |
|---|---|
| Perf Week | 0.87% |
| Perf Month | 19.64% |
| Perf Quarter | -28.96% |
| Perf Half Y | -7.66% |
| Perf YTD | -4.17% |
| Perf Year | -6.57% |
| Perf 3Y | 52.07% |
| Perf 5Y | -75.15% |
| Recommendation | 1.00 |
| Target Price | 46.78 |
| Prev Close | 22.05 |
| Price | 22.05 |
| Change % | 0.00% |